The heterogeneity of ovarian cancer.

Ovarian cancer carries the worst prognosis of all gynecological malignancies. This is mainly due to its resistance against commonly used cytostatic dr...
149KB Sizes 0 Downloads 0 Views

Recommend Documents


Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer.
A cornerstone of preclinical cancer research has been the use of clonal cell lines. However, this resource has underperformed in its ability to effectively identify novel therapeutics and evaluate the heterogeneity in a patient's tumor. The patient-d

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins.
To investigate tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group (PcG) proteins.

Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy.
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy, and tumoural heterogeneity (TH) has been blamed for treatment failure. The genomic and epigenomic atlas of EOC varies significantly with tumour histotype, grade, stage, sen

Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.
Malignant ascites constitute a unique tumor microenvironment providing a physical structure for the accumulation of cellular and acellular components. Ascites is initiated and maintained by physical and biological factors resulting from underlying di

Mutational heterogeneity in non-serous ovarian cancers.
Epithelial ovarian cancer is a leading cause of death in gynecological cancers. While several systematic studies have revealed the mutation landscape of serous epithelial ovarian cancer, other non-serous subtypes of the disease have not been explored

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing.
The extent to which metastatic tumors further evolve by accumulating additional mutations is unclear and has yet to be addressed extensively using next-generation sequencing of high-grade serous ovarian cancer.

Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide, despite gains in diagnostics and treatments made over the last three decades. Existing markers of ovarian cancer possess very limited cl

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.
Epithelial ovarian cancer exhibits extensive interpatient and intratumoral heterogeneity, which can hinder successful treatment strategies. Herein, we investigated the efficacy of an emerging oncolytic, Maraba virus (MRBV), in an in vitro model of ov

Heterogeneity of ovarian theca and interstitial gland cells in mice.
It has been established that two developmentally and functionally distinct cell types emerge within the mammalian testis and adrenal gland throughout life. Fetal and adult types of steroidogenic cells (i.e., testicular Leydig cells and adrenocortical

[Heterogeneity of epithelial ovarian carcinomas and their clinical significance].
Le cancer épithélial de l'ovaire, malgré des thérapies améliorées, est une des tumeurs gynécologiques ayant une létalité très elevée. De nouvelles études génétiques moléculaires indiquent qu'il s'agit d'une maladie hétérogène, ce qui se reflète égale